Overcoming Obstacles of The Canadian Drug Regulatory Landscape

The Canadian Drug Approval Process is misunderstood by many and considered harsh by some. We will explore reasons why the Canadian market should not be overlooked and the benefits of including Canada in strategic drug development initiatives. We will share insights and practical examples that facilitate a positive, proactive and transparent interaction with Health Canada, and provide strategies for avoiding obstacles and managing them efficiently should they occur.

Purchase option for this webinar is currently unavailable. Please contact our Customer Care for more info.
Customer Care

Fax: +1-650-362-2367

Email: customercare@fdatrainingalert.com

Follow us:
Why Should You Attend:

Learn about common obstacles in the Canadian Drug Development and Approval Process and how to avoid them/overcome them. We will discuss each obstacle in detail and deliver actionable tools to improve your efficiency and increase opportunities for successful market access. You will develop a comprehensive understanding of the Drug Approval Process and in parallel examine major misconceptions and misunderstandings. Our focus will be on key strategic considerations at various stages of the Drug Development Process as well as on demystifying the broader principals of the drug registration approach in Canada.

Areas Covered in the Webinar:
  • A comprehensive overview of the Drug Approval Process, including major misconceptions and misunderstandings.
  • What common obstacles are in the Canadian Drug Development and Approval Process and how to avoid / manage them.
  • Key strategic considerations at various stages of the Drug Development Process.
  • The broader principals of the drug registration approach in Canada.
  • Tips that will improve your efficiency and increase opportunities for successful market access.
Who Will Benefit:
  • This webinar is for individuals and companies currently working in a regulatory or business development capacity and considering the demographically desirable Canadian market. Participants will leave with a clear understanding of what the Canadian regulatory landscape is and be able to apply learned principals for avoiding/overcoming the most common obstacles of the Canadian Regulatory environment. Biotech C-suite, decision makers and study sponsors will benefit from participating.
Instructor Profile:
Susanne Picard Susanne Picard

Founder and President, SPharm Inc

Founder and President of SPharm, Susanne Picard is a sought-after expert on all aspects of the regulatory landscape. SPharm is a leading regulatory affairs consultancy headquartered in Canada that services clients around the globe. spicard@spharm-inc.com.

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

You Recently Viewed